A recent letter to the NEJM gives some pause on Advair. The problem is with the salmeterol component, which can lead to clinical worsening if given during an acute asthma attack.
More warnings on Advair
Real physician voices, twice a week
Free, and one click to unsubscribe.
Keep reading
The Podcast
Latest episodes
Most popular
Alzheimer’s treatment works best early, so why are patients waiting?
Doctors can spot a failing patient. Can they spot a failing hospital?
Clinical trials answer drug questions. Health questions need other tools.
Changing careers in medicine? Ask yourself, not everyone else
Doctor or nurse? The hospital assumptions that put patients at risk
Is your clinical AI tool safe? 4 questions to ask first
Hidden fees in employer health plans are about to come out
